Marelize Swart

772 total citations
26 papers, 607 citations indexed

About

Marelize Swart is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Marelize Swart has authored 26 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Virology and 6 papers in Oncology. Recurrent topics in Marelize Swart's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Drug Transport and Resistance Mechanisms (6 papers). Marelize Swart is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Drug Transport and Resistance Mechanisms (6 papers). Marelize Swart collaborates with scholars based in South Africa, United States and Zimbabwe. Marelize Swart's co-authors include Collet Dandara, Peter J. Smith, Yuan Ren, Michelle Skelton, Collen Masimirembwa, Ambroise Wonkam, Zeruesenay Desta, Andrea Gaedigk, Simbarashe Takuva and David W. Haas and has published in prestigious journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Antiviral Research.

In The Last Decade

Marelize Swart

26 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marelize Swart South Africa 14 244 232 145 117 106 26 607
Ron van Schaik Netherlands 9 173 0.7× 147 0.6× 97 0.7× 104 0.9× 113 1.1× 29 553
P. Neuhaus Germany 8 131 0.5× 288 1.2× 76 0.5× 126 1.1× 202 1.9× 11 652
Rubin Lubomirov Spain 13 374 1.5× 162 0.7× 239 1.6× 98 0.8× 132 1.2× 38 717
Heike Tegude Germany 8 185 0.8× 328 1.4× 107 0.7× 113 1.0× 360 3.4× 9 704
Marie‐Claude Gagnieu France 19 278 1.1× 64 0.3× 71 0.5× 169 1.4× 145 1.4× 63 889
Olena Kis Canada 10 231 0.9× 37 0.2× 132 0.9× 135 1.2× 212 2.0× 15 541
Jan‐Stefan van der Walt South Africa 12 167 0.7× 64 0.3× 41 0.3× 68 0.6× 120 1.1× 21 532
Sylvie Quaranta France 11 83 0.3× 123 0.5× 33 0.2× 153 1.3× 181 1.7× 27 403
Emmanuel Chigutsa United States 15 526 2.2× 122 0.5× 73 0.5× 94 0.8× 118 1.1× 28 857
Thawinee Jantararoungtong Thailand 17 143 0.6× 147 0.6× 56 0.4× 72 0.6× 36 0.3× 28 1.1k

Countries citing papers authored by Marelize Swart

Since Specialization
Citations

This map shows the geographic impact of Marelize Swart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marelize Swart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marelize Swart more than expected).

Fields of papers citing papers by Marelize Swart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marelize Swart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marelize Swart. The network helps show where Marelize Swart may publish in the future.

Co-authorship network of co-authors of Marelize Swart

This figure shows the co-authorship network connecting the top 25 collaborators of Marelize Swart. A scholar is included among the top collaborators of Marelize Swart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marelize Swart. Marelize Swart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desta, Zeruesenay, Roseann S. Gammal, Li Gong, et al.. (2019). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy. PMC. 19 indexed citations
2.
Swart, Marelize & Collet Dandara. (2019). MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro : Clinical Implications. OMICS A Journal of Integrative Biology. 23(10). 496–507. 8 indexed citations
3.
Swart, Marelize, Victoria M. Pratt, Patrick J. Kiel, et al.. (2019). Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology. Journal of Molecular Diagnostics. 21(3). 491–502. 4 indexed citations
4.
Swart, Marelize, et al.. (2018). Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. PMC. 1 indexed citations
5.
Collins, Kimberly S., Victoria M. Pratt, Marelize Swart, et al.. (2018). Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy. Pharmacogenetics and Genomics. 29(1). 18–22. 9 indexed citations
6.
Swart, Marelize, et al.. (2018). Pharmacogenetics and Practice: Tailoring Prescribing for Safety and Effectiveness. The Journal for Nurse Practitioners. 14(10). 697–704.e1. 7 indexed citations
7.
Swart, Marelize, et al.. (2018). Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. Genetic Testing and Molecular Biomarkers. 22(11). 652–655. 2 indexed citations
8.
Ipe, Joseph, Marelize Swart, Ingrid F. Metzger, et al.. (2017). Variants in theCYP2B63′UTR AlterIn VitroandIn VivoCYP2B6 Activity: Potential Role of MicroRNAs. Clinical Pharmacology & Therapeutics. 104(1). 130–138. 19 indexed citations
9.
Dandara, Collet, Marelize Swart, Renate Strehlau, et al.. (2015). Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation. BMC Infectious Diseases. 16(1). 56–56. 23 indexed citations
10.
Lacerda, Miguel, Sandra Castel, Marelize Swart, et al.. (2015). Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients. OMICS A Journal of Integrative Biology. 19(9). 553–562. 15 indexed citations
11.
12.
13.
Ross, Ian Louis, Collet Dandara, Marelize Swart, et al.. (2014). 9β Polymorphism of the Glucocorticoid Receptor Gene Appears to Have Limited Impact in Patients with Addison’s Disease. PLoS ONE. 9(1). e86350–e86350. 5 indexed citations
14.
Dandara, Collet, et al.. (2014). Cytochrome P450 pharmacogenetics in African populations: implications for public health. Expert Opinion on Drug Metabolism & Toxicology. 10(6). 769–785. 44 indexed citations
15.
Bienvenu, Emile, Marelize Swart, Collet Dandara, & Michael Ashton. (2013). The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients. Antiviral Research. 102. 44–53. 15 indexed citations
16.
Swart, Marelize, Michelle Skelton, Yuan Ren, et al.. (2013). High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients. Pharmacogenetics and Genomics. 23(8). 415–427. 58 indexed citations
17.
Bienvenu, Emile, Marelize Swart, Collet Dandara, et al.. (2013). Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations. Current pharmacogenomics and personalized medicine (Online). 11(3). 237–246. 6 indexed citations
18.
Swart, Marelize, et al.. (2012). PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients. BMC Medical Genetics. 13(1). 112–112. 43 indexed citations
19.
Swart, Marelize, Yuan Ren, Peter J. Smith, & Collet Dandara. (2012). ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients. Frontiers in Genetics. 3. 236–236. 43 indexed citations
20.
Swart, Marelize, et al.. (2012). CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics. Current pharmacogenomics and personalized medicine (Online). 10(1). 43–53. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron van Schaik Breakdown of academic impact, for papers by P. Neuhaus Breakdown of academic impact, for papers by Rubin Lubomirov Breakdown of academic impact, for papers by Heike Tegude Breakdown of academic impact, for papers by Marie‐Claude Gagnieu Breakdown of academic impact, for papers by Olena Kis Breakdown of academic impact, for papers by Jan‐Stefan van der Walt Breakdown of academic impact, for papers by Sylvie Quaranta Breakdown of academic impact, for papers by Emmanuel Chigutsa Breakdown of academic impact, for papers by Thawinee Jantararoungtong
Rankless by CCL
2026